Praxair, Inc. and Subsidiaries
(Millions of dollars)
DECEMBER 31,
2003
2002
2001
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
       
OPERATIONS
Net income
$585
$409
$430
Adjustments to reconcile net income to net cash
provided by operating activities
Depreciation and amortization
517
483
499
Accounting change
139
Special charges
58
Deferred income taxes
33
37
36
Non-cash charges (benefits) and other
21
3
(11)
Working capital
Accounts receivable
(96)
6
46
Inventories
(22)
4
20
Prepaid and other current assets
(19)
4
11
Payables and accruals
78
(41)
(22)
Long-term assets, liabilities and other
40
(43)
(47)
Net cash provided by operating activities
1,137
1,001
1,020
INVESTING
Capital expenditures (Note 5)
(983)
(498)
(595)
Acquisitions
(73)
(113)
(213)
Divestitures and asset sales
64
24
45
Net cash used for investing activities
(992)
(587)
(763)
FINANCING
Short-term debt borrowings (repayments) ­ net
(94)
67
21
Long-term debt borrowings
1,432
1,116
273
Long-term debt repayments
(1,295)
(1,428)
(483)
Minority interest transactions and other
(5)
27
(14)
Issuances of common stock
246
206
142
Purchases of common stock
(271)
(276)
(76)
Cash dividends
(149)
(123)
(110)
Net cash used for financing activities
(136)
(411)
(247)
Effect of exchange rate changes on cash and cash equivalents
2
(3)
(2)
Change in cash and cash equivalents
11
8
Cash and cash equivalents, beginning-of-year
39
39
31
Cash and cash equivalents, end-of-year
$  50
$  39
$  39
SUPPLEMENTAL DATA
Taxes paid
$109
$  65
$  57
Interest paid
$168
$210
$219
Tax benefits from stock option exercises
$  24
$  23
$  20
Debt from consolidation of equity companies (Note 14)
$    9
$   —
$  65
The accompanying Notes are an integral part of these financial statements.